Paulo Henrique Pires de Aguiar

Paulo Henrique Pires de Aguiar

Auto-generated profile, based on publicly available information

Paulo Henrique Pires de Aguiar

Faculdade de Ciências Médicas e da Saúde Pontifícia Universidade Católica de São Paulo (PUC‐SP) Sorocaba São Paulo Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in World Neurosurgery
Verified
Journal Article
Closed access
MAMarcus André Acioly
Marcus André Acioly
MLMarina Liebsch
Marina Liebsch
PAPaulo Henrique Pires de Aguiar
Paulo Henrique Pires de Aguiar
MTMarcos Tatagiba
Marcos Tatagiba

1 September 2009 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
PAPaulo Henrique Pires de Aguiar
Paulo Henrique Pires de Aguiar
ATAdriana Tahara
Adriana Tahara
AAAntonio Nogueira Almeida
Antonio Nogueira Almeida
RSRenata Simm
Renata Simm
ASArnaldo Neves da Silva
Arnaldo Neves da Silva
PSPedro Gabriel Silva
Pedro Gabriel Silva

1 May 2009 in Neurosurgery
Verified
Journal Article
Closed access
RPRonie L. Piske
Ronie L. Piske
LKLuis H. Kanashiro
Luis H. Kanashiro
EPEric Paschoal
Eric Paschoal
CACelso Agner
Celso Agner
SLSergio S. Lima
Sergio S. Lima
PAPaulo H. Aguiar
Paulo H. Aguiar
We report our results using Onyx HD-500 (Micro Therapeutics, Inc., Irvine, CA) in the endovascular treatment of wide-neck intracranial aneurysms, which have a high rate of incomplete occlusion and recanalization with platinum coils. Sixty-nine patients with 84 aneurysms were treated. Most of the aneurysms were located in the anterior circulation (80 of 84 aneurysms), were unruptured (74 of 84 aneurysms), and were incidental. Ten presented with subarachnoid hemorrhage, and 15 were symptomatic. All aneurysms had wide necks (neck >4 mm and/or dome-to-neck ratio <1.5). Fifty aneurysms were small (<12 mm), 30 were large (12 to <25 mm) and 4 were giant. Angiographic follow-up was available for 65 of the 84 aneurysms at 6 months, for 31 of the 84 aneurysms at 18 months, and for 5 of the 84 aneurysms at 36 months. Complete aneurysm occlusion was seen in 65.5% of aneurysms on immediate control, in 84.6% at 6 months, and in 90.3% at 18 months. The rates of complete occlusion were 74%, 95.1%, and 95.2% for small aneurysms and 53.3%, 70%, and 80% for large aneurysms at the same follow-up periods. Progression from incomplete to complete occlusion was seen in 68.2% of all aneurysms, with a higher percentage in small aneurysms (90.9%). Aneurysm recanalization was observed in 3 patients (4.6%), with retreatment in 2 patients (3.3%). Procedural mortality was 2.9%. Overall morbidity was 7.2%. Onyx embolization of intracranial wide-neck aneurysms is safe and effective. Morbidity and mortality rates are similar to those of other current endovascular techniques. Larger samples and longer follow-up periods are necessary.

15 August 2018 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
BPBenedito Jamilson Araújo Pereira
Benedito Jamilson Araújo Pereira
AAAntônio Nogueira de Almeida
Antônio Nogueira de Almeida
Wellingson PaivaWellingson Paiva
Wellingson Paiva
PAPaulo Henrique Pires de Aguiar
Paulo Henrique Pires de Aguiar
MTManoel Jacobsen Teixeira
Manoel Jacobsen Teixeira
SMSuely Kazue Nagahashi Marie
Suely Kazue Nagahashi Marie

1 May 2009 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
ATAdriana Tahara
Adriana Tahara
PSPedro Augustto de Santana
Pedro Augustto de Santana
MMMarcos Vinicius Calfat Maldaun
Marcos Vinicius Calfat Maldaun
APAlexandros Theodoros Panagopoulos
Alexandros Theodoros Panagopoulos
ASArnaldo Neves da Silva
Arnaldo Neves da Silva
PAPaulo Henrique Pires de Aguiar
Paulo Henrique Pires de Aguiar

1 December 2010 in Neurological Research
Verified
Journal Article
Closed access
PAPaulo Henrique Pires de Aguiar
Paulo Henrique Pires de Aguiar
RARogério Aires
Rogério Aires
ELEdward R. Laws
Edward R. Laws
GIGustavo Rassier Isolan
Gustavo Rassier Isolan
ALAngela Logullo
Angela Logullo
LKLaurence Katznelson
Laurence Katznelson
The present article presents an overview of the literature, and analyses the methods and the primary questions related to assessment of proliferation index using the Ki-67/MIB-1 labeling index in pituitary adenomas. Although atypical adenomas are characterized by their atypical morphological features by an elevated mitotic index, a Ki-67 (MIB-1) labeling index greater than 3% and extensive nuclear staining for p53, use of the proliferation index (LI) of pituitary adenomas in assessing the degree of tumor aggressiveness is a controversial topic in the literature, and there are disparate results involving many studies. A review of literature was carried out to correlate the role of Ki-67 LI and its correlation with clinical findings, tumor size, invasiveness, recurrence, adenoma subtype, adenoma doubling time, and pituitary carcinomas is addressed. The prognosis cannot be predicted on the basis of the Ki-67 LI alone. Although there is no direct relation between Ki-67 LI and some of these variables and controversial data were found regarding some topics, our review justify the use of Ki-67 in the analysis of pituitary adenomas as an additional information for clinical decision. Although assessment of proliferative may be helpful in predicting subsequent tumor recurrence or invasiveness, there are many other important and as yet unidentified factors pituitary tumors. It is clear that further research is needed to clarify these molecular mechanisms to predict those with a potentially poor clinical outcome.